Development of myeloperoxidase-antineutrophil cytoplasmic antibody-associated renal vasculitis in a patient receiving treatment with anti-tumor necrosis factor-α-Reference-Cited by-同舟云学术

Development of myeloperoxidase-antineutrophil cytoplasmic antibody-associated renal vasculitis in a patient receiving treatment with anti-tumor necrosis factor-α

Published:2010-12 Issue:6 Volume:20 Page:602-605
ISSN:1439-7595
Container-title:Modern Rheumatology
language:en
Short-container-title:Modern Rheumatology

Author:

Hirohama Daigoro,Hoshino Junichi,Hasegawa Eiko,Yamanouchi Masayuki,Hayami Noriko,Suwabe Tatsuya,Sawa Naoki,Takemoto Fumi,Ubara Yoshifumi,Hara Shigeko,Ohashi Kenichi,Takaichi Kenmei

Publisher

Oxford University Press (OUP)

Subject

Rheumatology

Link

http://www.tandfonline.com/doi/pdf/10.3109/s10165-010-0339-x

Reference20 articles.

1. Differentiating the efficacy of the tumor necrosis factor inhibitors

2. Efficacy, Tolerability and Cost Effectiveness of Disease-Modifying Antirheumatic Drugs and Biologic Agents in Rheumatoid Arthritis

3. Anti-TNF agents for rheumatoid arthritis

4. Antineutrophil cytoplasmic antibody-associated necrotizing crescentic glomerulonephritis in a patient receiving treatment with etanercept for severe rheumatoid arthritis

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathologic Spectrum of Renal Lesions Following Anti-TNF-α Inhibitor Therapy: A Single Center Experience;Kidney360;2023-03

2. Rapidly progressive glomerulonephritis after introduction of certolizumab pegol: a case report;Modern Rheumatology Case Reports;2020-07-31

3. Small- and Medium-Vessel Primary Vasculitis;Clinical Immunology;2019

4. Nephrotoxicity of Select Rheumatologic Drugs;Rheumatic Disease Clinics of North America;2018-11

5. Acute Tubulointerstitial Nephritis Associated with Infliximab in a Patient with Crohn's Disease;Internal Medicine;2016